공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 공캡슐 시장

Empty Capsules

리서치사 Global Industry Analysts, Inc.
발행일 2021년 04월 상품 코드 997453
페이지 정보 영문 275 Pages
가격
US $ 5,450 ₩ 6,193,000 PDF (Single User License) help
DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste 가 되지 않으며, 인쇄는 1회에 한해 가능합니다. 인쇄물 이용은 PDF 라이선스 소유자로 한정됩니다.
US $ 16,350 ₩ 18,580,000 PDF (Global License to Company and its Fully-owned Subsidiaries) help
동일 기업 및 100% 자회사의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 공캡슐 시장 Empty Capsules
발행일 : 2021년 04월 페이지 정보 : 영문 275 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 공캡슐 시장 규모는 분석기간(2020-2027년)에 5.8%의 연평균 복합 성장률(CAGR)로 성장할 전망이며, 2020년 18억 달러에서 2027년에는 27억 달러에 달할 것으로 예측됩니다.

본 보고서에서 분석한 부문 중 하나인 젤라틴은 분석기간 중 5.9%의 CAGR을 나타내고, 22억 달러에 달할 전망입니다.

세계의 공캡슐(Empty Capsules) 시장에 대해 조사했으며, 시장 점유율, COVID-19의 영향, 동향 및 성장요인, 지역별 시장 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

조사 대상 기업 예

  • ACG Worldwide Pvt., Ltd.
  • Bright Pharmacaps Inc.
  • Capscanada Corporation
  • Capsugel, Inc.
  • Healthcaps India Limited
  • Medi-Caps Ltd.
  • Natural Capsules Ltd.
  • Nectar Lifesciences Ltd.
  • Qingdao Yiqing Medicinal Capsules Co., Ltd.
  • Qualicaps, Inc.
  • Roxlor, LLC
  • Snail Pharma Industry Co., Ltd.
  • Suheung Co Ltd.
  • Sunil Healthcare

목차

I. 조사 방법

II. 개요

  • 시장 개요
    • 인플루언서 시장 인사이트
    • 꾸준한 성장을 기록하기 위한 공캡슐 시장
    • 코로나19(COVID-19)의 영향과 다가오는 세계 경기침체
  • 주요 기업
    • 경쟁
  • 동향 및 성장요인
    • 고령 인구 급증에 의한 시장 성장 촉진
    • 수요에 박차를 가하는 의약품 시장 성장
    • 시장 수요를 지원하는 의약품 연구개발과 임상시험 성장
    • 약물전달 시스템의 기술적 진보에 따른 시장 이익 전망
    • 시장 성장을 촉진하는 스포츠 영양의 중요성 증가
    • 화장품 및 식이보충제 산업에서의 공캡슐 용도 확대에 의한 수요 증가
  • 세계 시장 전망

III. 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

IV. 경쟁

  • 기업 개요 : 44개사
LSH 21.04.08

Abstract:

Global Empty Capsules Market to Reach $2.7 Billion by 2027

Amid the COVID-19 crisis, the global market for Empty Capsules estimated at US$1.8 Billion in the year 2020, is projected to reach a revised size of US$2.7 Billion by 2027, growing at aCAGR of 5.8% over the period 2020-2027. Gelatin, one of the segments analyzed in the report, is projected to record 5.9% CAGR and reach US$2.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Non-Gelatin segment is readjusted to a revised 5.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $530.7 Million, While China is Forecast to Grow at 5.4% CAGR

The Empty Capsules market in the U.S. is estimated at US$530.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$469.3 Million by the year 2027 trailing a CAGR of 5.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.5% and 4.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Select Competitors (Total 44 Featured) -

  • ACG Worldwide Pvt., Ltd.
  • Bright Pharmacaps Inc.
  • Capscanada Corporation
  • Capsugel, Inc.
  • Healthcaps India Limited
  • Medi-Caps Ltd.
  • Natural Capsules Ltd.
  • Nectar Lifesciences Ltd.
  • Qingdao Yiqing Medicinal Capsules Co., Ltd.
  • Qualicaps, Inc.
  • Roxlor, LLC
  • Snail Pharma Industry Co., Ltd.
  • Suheung Co Ltd.
  • Sunil Healthcare

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Empty Capsules Market to Register Steady Growth
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
    • Competition
    • EXHIBIT 1: Market Share of Leading Players by Product Sales: 2018
  • 3. MARKET TRENDS & DRIVERS
    • Rapid Growth in Ageing Population Drives Market Growth
    • EXHIBIT 2: Global Population Statistics and Estimates for the 60+ Age Group (1990, 2015, 2050E, 2100E)
    • Growth in Pharmaceutical Market to Spur Demand
    • EXHIBIT 3: Worldwide Pharmaceutical Market Growth by region: 2017 and 2022E
    • Growth in Pharmaceutical R&D and Clinical Trials to Support Market Demand
    • EXHIBIT 4: Expenditure (in Billion USD) of Pharmaceutical R&D in the US: 1980-2017)
    • EXHIBIT 5: Total Registered Studies Number: 2000-2021
    • With Increase in Technological Advancements of Drug Delivery Systems, the Market is expected to Register Gains
    • Increasing Importance for Sports Nutrition to Bolster Market Growth
    • EXHIBIT 6: Global Market Value (in Billion USD) of Sports Nutrition: 2014-2024
    • EXHIBIT 7: Total Market Value (in Billion USD) of Sports Nutrition in North America: 2011-2021E
    • Growing Application of Empty Capsules in Cosmetics and Nutraceutical Industries to Bolster Demand
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Empty Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Empty Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Empty Capsules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Gelatin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Gelatin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Gelatin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Non-Gelatin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Non-Gelatin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Non-Gelatin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Immediate-Release Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Immediate-Release Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Immediate-Release Capsules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Sustained-Release Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Sustained-Release Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Sustained-Release Capsules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Delayed-Release Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Delayed-Release Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Delayed-Release Capsules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Antibiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Antibiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Antibiotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Vitamins and Dietary Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Vitamins and Dietary Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Vitamins and Dietary Supplements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Antacid & Antiflatulent Preparations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 26: World Historic Review for Antacid & Antiflatulent Preparations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 27: World 15-Year Perspective for Antacid & Antiflatulent Preparations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 28: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 29: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 30: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 31: World Current & Future Analysis for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 32: World Historic Review for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 33: World 15-Year Perspective for Pharmaceutical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 34: World Current & Future Analysis for Nutraceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 35: World Historic Review for Nutraceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 36: World 15-Year Perspective for Nutraceutical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 37: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 38: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 39: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 40: USA Current & Future Analysis for Empty Capsules by Product - Gelatin and Non-Gelatin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 41: USA Historic Review for Empty Capsules by Product - Gelatin and Non-Gelatin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 42: USA 15-Year Perspective for Empty Capsules by Product - Percentage Breakdown of Value Sales for Gelatin and Non-Gelatin for the Years 2012, 2020 & 2027
    • TABLE 43: USA Current & Future Analysis for Empty Capsules by Functionality - Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: USA Historic Review for Empty Capsules by Functionality - Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 45: USA 15-Year Perspective for Empty Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules for the Years 2012, 2020 & 2027
    • TABLE 46: USA Current & Future Analysis for Empty Capsules by Application - Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 47: USA Historic Review for Empty Capsules by Application - Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 48: USA 15-Year Perspective for Empty Capsules by Application - Percentage Breakdown of Value Sales for Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 49: USA Current & Future Analysis for Empty Capsules by End-Use - Pharmaceutical, Nutraceutical and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 50: USA Historic Review for Empty Capsules by End-Use - Pharmaceutical, Nutraceutical and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 51: USA 15-Year Perspective for Empty Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Nutraceutical and Other End-Uses for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 52: Canada Current & Future Analysis for Empty Capsules by Product - Gelatin and Non-Gelatin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Canada Historic Review for Empty Capsules by Product - Gelatin and Non-Gelatin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 54: Canada 15-Year Perspective for Empty Capsules by Product - Percentage Breakdown of Value Sales for Gelatin and Non-Gelatin for the Years 2012, 2020 & 2027
    • TABLE 55: Canada Current & Future Analysis for Empty Capsules by Functionality - Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Canada Historic Review for Empty Capsules by Functionality - Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 57: Canada 15-Year Perspective for Empty Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules for the Years 2012, 2020 & 2027
    • TABLE 58: Canada Current & Future Analysis for Empty Capsules by Application - Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 59: Canada Historic Review for Empty Capsules by Application - Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 60: Canada 15-Year Perspective for Empty Capsules by Application - Percentage Breakdown of Value Sales for Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 61: Canada Current & Future Analysis for Empty Capsules by End-Use - Pharmaceutical, Nutraceutical and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 62: Canada Historic Review for Empty Capsules by End-Use - Pharmaceutical, Nutraceutical and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 63: Canada 15-Year Perspective for Empty Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Nutraceutical and Other End-Uses for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 64: Japan Current & Future Analysis for Empty Capsules by Product - Gelatin and Non-Gelatin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 65: Japan Historic Review for Empty Capsules by Product - Gelatin and Non-Gelatin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 66: Japan 15-Year Perspective for Empty Capsules by Product - Percentage Breakdown of Value Sales for Gelatin and Non-Gelatin for the Years 2012, 2020 & 2027
    • TABLE 67: Japan Current & Future Analysis for Empty Capsules by Functionality - Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Japan Historic Review for Empty Capsules by Functionality - Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 69: Japan 15-Year Perspective for Empty Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules for the Years 2012, 2020 & 2027
    • TABLE 70: Japan Current & Future Analysis for Empty Capsules by Application - Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Japan Historic Review for Empty Capsules by Application - Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 72: Japan 15-Year Perspective for Empty Capsules by Application - Percentage Breakdown of Value Sales for Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 73: Japan Current & Future Analysis for Empty Capsules by End-Use - Pharmaceutical, Nutraceutical and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Japan Historic Review for Empty Capsules by End-Use - Pharmaceutical, Nutraceutical and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 75: Japan 15-Year Perspective for Empty Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Nutraceutical and Other End-Uses for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 76: China Current & Future Analysis for Empty Capsules by Product - Gelatin and Non-Gelatin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 77: China Historic Review for Empty Capsules by Product - Gelatin and Non-Gelatin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 78: China 15-Year Perspective for Empty Capsules by Product - Percentage Breakdown of Value Sales for Gelatin and Non-Gelatin for the Years 2012, 2020 & 2027
    • TABLE 79: China Current & Future Analysis for Empty Capsules by Functionality - Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 80: China Historic Review for Empty Capsules by Functionality - Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 81: China 15-Year Perspective for Empty Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules for the Years 2012, 2020 & 2027
    • TABLE 82: China Current & Future Analysis for Empty Capsules by Application - Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 83: China Historic Review for Empty Capsules by Application - Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 84: China 15-Year Perspective for Empty Capsules by Application - Percentage Breakdown of Value Sales for Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 85: China Current & Future Analysis for Empty Capsules by End-Use - Pharmaceutical, Nutraceutical and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 86: China Historic Review for Empty Capsules by End-Use - Pharmaceutical, Nutraceutical and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 87: China 15-Year Perspective for Empty Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Nutraceutical and Other End-Uses for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 88: Europe Current & Future Analysis for Empty Capsules by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 89: Europe Historic Review for Empty Capsules by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 90: Europe 15-Year Perspective for Empty Capsules by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 91: Europe Current & Future Analysis for Empty Capsules by Product - Gelatin and Non-Gelatin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Europe Historic Review for Empty Capsules by Product - Gelatin and Non-Gelatin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 93: Europe 15-Year Perspective for Empty Capsules by Product - Percentage Breakdown of Value Sales for Gelatin and Non-Gelatin for the Years 2012, 2020 & 2027
    • TABLE 94: Europe Current & Future Analysis for Empty Capsules by Functionality - Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Europe Historic Review for Empty Capsules by Functionality - Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 96: Europe 15-Year Perspective for Empty Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules for the Years 2012, 2020 & 2027
    • TABLE 97: Europe Current & Future Analysis for Empty Capsules by Application - Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Europe Historic Review for Empty Capsules by Application - Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 99: Europe 15-Year Perspective for Empty Capsules by Application - Percentage Breakdown of Value Sales for Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 100: Europe Current & Future Analysis for Empty Capsules by End-Use - Pharmaceutical, Nutraceutical and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 101: Europe Historic Review for Empty Capsules by End-Use - Pharmaceutical, Nutraceutical and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 102: Europe 15-Year Perspective for Empty Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Nutraceutical and Other End-Uses for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 103: France Current & Future Analysis for Empty Capsules by Product - Gelatin and Non-Gelatin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 104: France Historic Review for Empty Capsules by Product - Gelatin and Non-Gelatin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 105: France 15-Year Perspective for Empty Capsules by Product - Percentage Breakdown of Value Sales for Gelatin and Non-Gelatin for the Years 2012, 2020 & 2027
    • TABLE 106: France Current & Future Analysis for Empty Capsules by Functionality - Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 107: France Historic Review for Empty Capsules by Functionality - Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 108: France 15-Year Perspective for Empty Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules for the Years 2012, 2020 & 2027
    • TABLE 109: France Current & Future Analysis for Empty Capsules by Application - Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 110: France Historic Review for Empty Capsules by Application - Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 111: France 15-Year Perspective for Empty Capsules by Application - Percentage Breakdown of Value Sales for Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 112: France Current & Future Analysis for Empty Capsules by End-Use - Pharmaceutical, Nutraceutical and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 113: France Historic Review for Empty Capsules by End-Use - Pharmaceutical, Nutraceutical and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 114: France 15-Year Perspective for Empty Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Nutraceutical and Other End-Uses for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 115: Germany Current & Future Analysis for Empty Capsules by Product - Gelatin and Non-Gelatin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 116: Germany Historic Review for Empty Capsules by Product - Gelatin and Non-Gelatin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 117: Germany 15-Year Perspective for Empty Capsules by Product - Percentage Breakdown of Value Sales for Gelatin and Non-Gelatin for the Years 2012, 2020 & 2027
    • TABLE 118: Germany Current & Future Analysis for Empty Capsules by Functionality - Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 119: Germany Historic Review for Empty Capsules by Functionality - Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 120: Germany 15-Year Perspective for Empty Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules for the Years 2012, 2020 & 2027
    • TABLE 121: Germany Current & Future Analysis for Empty Capsules by Application - Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 122: Germany Historic Review for Empty Capsules by Application - Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 123: Germany 15-Year Perspective for Empty Capsules by Application - Percentage Breakdown of Value Sales for Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 124: Germany Current & Future Analysis for Empty Capsules by End-Use - Pharmaceutical, Nutraceutical and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 125: Germany Historic Review for Empty Capsules by End-Use - Pharmaceutical, Nutraceutical and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 126: Germany 15-Year Perspective for Empty Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Nutraceutical and Other End-Uses for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 127: Italy Current & Future Analysis for Empty Capsules by Product - Gelatin and Non-Gelatin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 128: Italy Historic Review for Empty Capsules by Product - Gelatin and Non-Gelatin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 129: Italy 15-Year Perspective for Empty Capsules by Product - Percentage Breakdown of Value Sales for Gelatin and Non-Gelatin for the Years 2012, 2020 & 2027
    • TABLE 130: Italy Current & Future Analysis for Empty Capsules by Functionality - Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 131: Italy Historic Review for Empty Capsules by Functionality - Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 132: Italy 15-Year Perspective for Empty Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules for the Years 2012, 2020 & 2027
    • TABLE 133: Italy Current & Future Analysis for Empty Capsules by Application - Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 134: Italy Historic Review for Empty Capsules by Application - Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 135: Italy 15-Year Perspective for Empty Capsules by Application - Percentage Breakdown of Value Sales for Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 136: Italy Current & Future Analysis for Empty Capsules by End-Use - Pharmaceutical, Nutraceutical and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 137: Italy Historic Review for Empty Capsules by End-Use - Pharmaceutical, Nutraceutical and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 138: Italy 15-Year Perspective for Empty Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Nutraceutical and Other End-Uses for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 139: UK Current & Future Analysis for Empty Capsules by Product - Gelatin and Non-Gelatin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 140: UK Historic Review for Empty Capsules by Product - Gelatin and Non-Gelatin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 141: UK 15-Year Perspective for Empty Capsules by Product - Percentage Breakdown of Value Sales for Gelatin and Non-Gelatin for the Years 2012, 2020 & 2027
    • TABLE 142: UK Current & Future Analysis for Empty Capsules by Functionality - Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 143: UK Historic Review for Empty Capsules by Functionality - Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 144: UK 15-Year Perspective for Empty Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules for the Years 2012, 2020 & 2027
    • TABLE 145: UK Current & Future Analysis for Empty Capsules by Application - Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 146: UK Historic Review for Empty Capsules by Application - Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 147: UK 15-Year Perspective for Empty Capsules by Application - Percentage Breakdown of Value Sales for Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 148: UK Current & Future Analysis for Empty Capsules by End-Use - Pharmaceutical, Nutraceutical and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 149: UK Historic Review for Empty Capsules by End-Use - Pharmaceutical, Nutraceutical and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 150: UK 15-Year Perspective for Empty Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Nutraceutical and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 151: Rest of Europe Current & Future Analysis for Empty Capsules by Product - Gelatin and Non-Gelatin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 152: Rest of Europe Historic Review for Empty Capsules by Product - Gelatin and Non-Gelatin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 153: Rest of Europe 15-Year Perspective for Empty Capsules by Product - Percentage Breakdown of Value Sales for Gelatin and Non-Gelatin for the Years 2012, 2020 & 2027
    • TABLE 154: Rest of Europe Current & Future Analysis for Empty Capsules by Functionality - Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 155: Rest of Europe Historic Review for Empty Capsules by Functionality - Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 156: Rest of Europe 15-Year Perspective for Empty Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules for the Years 2012, 2020 & 2027
    • TABLE 157: Rest of Europe Current & Future Analysis for Empty Capsules by Application - Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 158: Rest of Europe Historic Review for Empty Capsules by Application - Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 159: Rest of Europe 15-Year Perspective for Empty Capsules by Application - Percentage Breakdown of Value Sales for Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 160: Rest of Europe Current & Future Analysis for Empty Capsules by End-Use - Pharmaceutical, Nutraceutical and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 161: Rest of Europe Historic Review for Empty Capsules by End-Use - Pharmaceutical, Nutraceutical and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 162: Rest of Europe 15-Year Perspective for Empty Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Nutraceutical and Other End-Uses for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 163: Asia-Pacific Current & Future Analysis for Empty Capsules by Product - Gelatin and Non-Gelatin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 164: Asia-Pacific Historic Review for Empty Capsules by Product - Gelatin and Non-Gelatin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 165: Asia-Pacific 15-Year Perspective for Empty Capsules by Product - Percentage Breakdown of Value Sales for Gelatin and Non-Gelatin for the Years 2012, 2020 & 2027
    • TABLE 166: Asia-Pacific Current & Future Analysis for Empty Capsules by Functionality - Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 167: Asia-Pacific Historic Review for Empty Capsules by Functionality - Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 168: Asia-Pacific 15-Year Perspective for Empty Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules for the Years 2012, 2020 & 2027
    • TABLE 169: Asia-Pacific Current & Future Analysis for Empty Capsules by Application - Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 170: Asia-Pacific Historic Review for Empty Capsules by Application - Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 171: Asia-Pacific 15-Year Perspective for Empty Capsules by Application - Percentage Breakdown of Value Sales for Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 172: Asia-Pacific Current & Future Analysis for Empty Capsules by End-Use - Pharmaceutical, Nutraceutical and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 173: Asia-Pacific Historic Review for Empty Capsules by End-Use - Pharmaceutical, Nutraceutical and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 174: Asia-Pacific 15-Year Perspective for Empty Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Nutraceutical and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 175: Rest of World Current & Future Analysis for Empty Capsules by Product - Gelatin and Non-Gelatin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 176: Rest of World Historic Review for Empty Capsules by Product - Gelatin and Non-Gelatin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 177: Rest of World 15-Year Perspective for Empty Capsules by Product - Percentage Breakdown of Value Sales for Gelatin and Non-Gelatin for the Years 2012, 2020 & 2027
    • TABLE 178: Rest of World Current & Future Analysis for Empty Capsules by Functionality - Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 179: Rest of World Historic Review for Empty Capsules by Functionality - Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 180: Rest of World 15-Year Perspective for Empty Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Capsules, Sustained-Release Capsules and Delayed-Release Capsules for the Years 2012, 2020 & 2027
    • TABLE 181: Rest of World Current & Future Analysis for Empty Capsules by Application - Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 182: Rest of World Historic Review for Empty Capsules by Application - Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 183: Rest of World 15-Year Perspective for Empty Capsules by Application - Percentage Breakdown of Value Sales for Antibiotics, Vitamins and Dietary Supplements, Antacid & Antiflatulent Preparations and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 184: Rest of World Current & Future Analysis for Empty Capsules by End-Use - Pharmaceutical, Nutraceutical and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 185: Rest of World Historic Review for Empty Capsules by End-Use - Pharmaceutical, Nutraceutical and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 186: Rest of World 15-Year Perspective for Empty Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Nutraceutical and Other End-Uses for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 44
Back to Top
전화 문의
F A Q